Short-term outcomes of cetuximab combined with standard chemotherapy as first line setting for Chinese patients with non-small cell lung cancer: A report of 12 cases

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Xia, Liang Ping ^a,b   Qiu, Hui Juan ^a,b   Chen, Xu Xian ^a,b   Hu, Pi Li ^a,b   Guo, Gui Fang ^a,b   Wang, Fang ^a,b   Zhou, Fei Fei ^c   He, Wen Zhuo ^a,b   Zhang, Bei ^a,b   Zhang, Li ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c THE FIRST PEOPLE S HOSPITAL OF FOSHAN   (China)

Author keywords

Cetuximab; Chemotherapy; Efficacy; First line; Non small cell lung cancer; Safety

Indexed keywords

CARBOPLATIN; CETUXIMAB; CISPLATIN; GEMCITABINE; PACLITAXEL; PEMETREXED;

ACNE LIKE RASH; ADULT; AGED; ARTICLE; CANCER STAGING; CHINESE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; FATIGUE; HUMAN; HYPOMAGNESEMIA; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OVERALL SURVIVAL; PARONYCHIA; PRIORITY JOURNAL; STOMATITIS; THROMBOCYTOPENIA;

EID: 84655176726     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9709-7     Document Type: Article

References (33)

1. R Rosell T Moran C Queralt 2009 Screening for epidermal growth factor receptor mutations in lung cancer N Engl J Med 361 10 958 967
2. TS Mok YL Wu S Thongprasert 2009 Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma N Engl J Med 361 10 947 957
3. M Maemondo A Inoue K Kobayashi 2010 Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N Engl J Med 362 25 2380 2388
4. FA Shepherd J Rodrigues Pereira T Ciuleanu 2005 Erlotinib in previously treated non-small-cell lung cancer N Engl J Med 353 2 123 132 (Pubitemid 41058344)
5. A Chang P Parikh S Thongprasert 2006 Gefitinib (IRESSA) in patients of Asian origin with refractory advanced non-small cell lung cancer: subset analysis from the ISEL study J Thorac Oncol 1 8 847 855 (Pubitemid 47181391)
6. Cappuzzo T Ciuleanu L Stelmah 2009 SATURN: a double-blind, randomized, phase III study of maintenance erlotinib versus placebo following non-progression with 1st-line platinum-based chemotherapy in patients with advanced NSCLC J Clin Oncol 27 18S 15s(abstr 8001)
7. T Hida I Okamoto T Kashii 2008 Randomized phase III study of platinum-doublet chemotherapy followed by gefitinib versus continued platinum-doublet chemotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Results of West Japan Thoracic Oncology Group trial (WJTOG) J Clin Oncol 26 15S 427s(LBA8012)
8. R Pirker JR Pereira A Szczesna 2009 Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial Lancet 373 9674 1525 1531
9. MA Socinski MN Saleh DF Trent 2009 A randomized, phase II trial of two dose schedules of carboplatin/paclitaxel/cetuximab in stage IIIB/IV non-small-cell lung cancer (NSCLC) Ann Oncol 20 6 1068 1073
10. H Borghaei CJ Langer M Millenson 2008 Phase II study of paclitaxel, carboplatin, and cetuximab as first line treatment, for patients with advanced non-small cell lung cancer (NSCLC): results of OPN-017 J Thorac Oncol 3 11 1286 1292
11. CP Belani MT Schreeder RG Steis 2008 Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study Cancer 113 9 2512 2517
12. CA Butts D Bodkin EL Middleman 2007 Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer J Clin Oncol 25 36 5777 5784
13. R Rosell G Robinet A Szczesna 2008 Randomized phase II study of cetuximab plus cisplatin/vinorelbine compared with cisplatin/vinorelbine alone as first-line therapy in EGFR-expressing advanced non-small-cell lung cancer Ann Oncol 19 2 362 369 (Pubitemid 351201721)
14. F Robert G Blumenschein RS Herbst 2005 Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer J Clin Oncol 23 36 9089 9096
15. CD Thienelt PA Bunn Jr N Hanna 2005 Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer J Clin Oncol 23 34 8786 8793 (Pubitemid 46211524)
16. TJ Lynch T Patel L Dreisbach 2010 Cetuximab and first-line Taxane/Carboplatin chemotherapy in advanced non-small-cell lung cancer: results of the randomized multicenter phase III trial BMS099 J Clin Oncol 28 6 911 917
17. Thatcher N, Linchy TJ, Butts CA, et al. Cetuximab plus platinum-based chemotherapy as 1st-line treatment in patients with non-small cell lung cancer(NSCLC)[C]:A meta-analysis of randomized phase II/III trails. WCLC 2009, oral presentation (abstract A3.7).
18. H Lin J Jiang X Liang 2010 Chemotherapy with cetuximab or chemotherapy alone for untreated advanced non-small-cell lung cancer: A systematic review and meta-analysis Lung Cancer 70 1 57 62
19. LP Xia YM Rong GF Guo 2010 The summary of efficacy of cetuximab combination with chemotherapy in NSCLC first-line setting: based on publication Chin-Ger J Clin Oncol 9 3 137 141
20. CJ Langer 2008 Will FLEX allow us flexibility in the therapy of advanced non-small-cell lung cancer? Insights from the 2008 American Society of Clinical Oncology Meeting Clin Lung Cancer 9 5 249 251
21. LP Xia Li Zhang B Zhang 2010 Short-term efficacy of patients with non-small cell lung cancer treated by cetuximab plus chemotherapy: review and 2 cases report J Oncol 16 2 133 138
22. F Wang LP Xia GF Guo 2010 Short-term outcomes of cetuximab combined with standard chemotherapy as non-first line setting for patients with Non-small cell lung cancer: a report of 6 cases Chin-Ger J Clin Oncol 9 9 502 506
23. LP Xia B Zang MZ Liu 2009 Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases Chin J Cancer (Chin) 29 9 977 982
24. Z Fan J Baselga H Masui 1993 Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts Cancer Res 53 19 4637 4642 (Pubitemid 23304392)
25. Z Fan Y Lu X Wu 1994 Antibody-induced epidermal growth factor receptor dimerization mediates inhibition of autocrine proliferation of A431 squamous carcinoma cells J Biol Chem 269 44 27595 27602 (Pubitemid 24346592)
26. LP Xia GF Guo HJ Qiu 2009 Efficacy and safety profiles of cetuximab in Chinese patients with colorectal cancer Chin-Ger J Clin Oncol 8 9 526 530
27. D Cunningham Y Humblet S Siena 2004 Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer N Engl J Med 351 4 337 345 (Pubitemid 38944402)
28. FR Hirsch RS Herbst C Olsen 2008 Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy J Clin Oncol 26 20 3351 3357
29. S Khambata-Ford CT Harbison LL Hart 2010 Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer J Clin Oncol 28 6 918 927
30. Gatzemeier U. FLEX: Cetuximab in combination with platinum-based chemotherapy (CT) improves survival versus chemotherapy (CT) alone in the 1st-line treatment of patients with advanced non-small cell lung caner(NSCLC)[C]. Data presented at the 2008 Chicago Multidisciplinary Symposium in Thoracic Oncology. J Thorac Oncol. 2008;3:S4. Abstract 8.
31. JA Bonner PM Harari J Giralt 2010 Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 1 21 28
32. A Jatoi EM Green KM Rowland Jr 2009 Clinical predictors of severe cetuximab-induced rash: observations from 933 patients enrolled in north central cancer treatment group study N0147 Oncology 77 2 120 123
33. GV Scagliotti P Parikh J von Pawel 2008 Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer J Clin Oncol 26 21 3543 3551